The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease
Abstract
Abstract Mildly increased serum bilirubin has recently been suggested as a protective factor, possibly reducing the risk of coronary artery disease (CAD) by acting as an antioxidant. We tested this hypothesis by examining serum bilirubin concentrations and other coronary risk factors in 120 men and 41 women with early familial CAD and 155 control subjects. At screening, both cases and control subjects were 38 to 68 years old. Early familial CAD patients had experienced myocardial infarction, coronary artery bypass grafting, or coronary angioplasty by age 55 years for men and 65 for women and had another sibling similarly affected. The average total serum bilirubin concentration was 8.9±6.1 μmol/L in cases and 12.4±8.1 μmol/L in control subjects (P=.0001 for difference). In univariate analysis stratified by sex, serum bilirubin was strongly and inversely related to CAD risk, with relative odds of 0.4 to 0.1 (relative to the lowest quintile,P=.04 to .00001) in both men and women as bilirubin increased into the upper two quintiles. Multiple logistic regression analysis was performed including age, sex, smoking, body mass index, diabetes, hypertension, plasma measured LDL cholesterol, HDL cholesterol, triglycerides, and serum bilirubin as potential risk factors. Bilirubin entered as an independent protective factor with an odds ratio of 0.25 (P=.0015) for an increase of 17 μmol/L (1 mg/dL). The standardized logistic regression coefficient for bilirubin was −.33 compared with −.34 for HDL, suggesting that the protective effect of bilirubin on CAD risk in the population is comparable to that of HDL cholesterol. A history of cigarette smoking was associated with significantly lower serum bilirubin concentration and appeared to attenuate the protective effect of bilirubin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study
Hertog, M. G. L., Feskens, E. J. M., Kromhout, D., Hertog, M. G. L., Hollman, P. C. H., Hertog, M. G. L., & Katan, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92876-u · Cited by 4,341
Bilirubin Is an Antioxidant of Possible Physiological Importance
Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1987) · Science · doi:10.1126/science.3029864 · Cited by 2,948
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282004 · Cited by 2,347
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine
Frankel, E. N., German, J. B., Kinsella, J. E., Parks, E., & Kanner, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90206-v · Cited by 1,647
Oxygen-radical absorbance capacity assay for antioxidants
Cao, G., Alessio, H. M., & Cutler, R. G. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90027-r · Cited by 1,605
Morrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,339
Inhibition of human LDL oxidation by resveratrol
Frankel, E. N., Waterhouse, A. L., & Kinsella, J. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92472-6 · Cited by 887
Antioxidant activity of albumin-bound bilirubin.
Stocker, R., Glazer, A. N., & Ames, B. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5918 · Cited by 766
Neuzil, J., & Stocker, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89449-8 · Cited by 508
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Wearable sensors: modalities, challenges, and prospects
Heikenfeld, J., Jajack, A., Rogers, J., Gutruf, P., Tian, L., Pan, T., Li, R., Khine, M., Kim, J., Wang, J., et al. (2018) · Lab on a Chip · doi:10.1039/c7lc00914c · Cited by 1,434
Bio-Integrated Wearable Systems: A Comprehensive Review
Ray, T. R., Choi, J., Bandodkar, A. J., Krishnan, S., Gutruf, P., Tian, L., Ghaffari, R., & Rogers, J. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00573 · Cited by 1,350
Biliverdin reductase: A major physiologic cytoprotectant
Barañano, D. E., Rao, M., Ferris, C. D., & Snyder, S. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252626999 · Cited by 1,088
Free heme toxicity and its detoxification systems in human
Kumar, S., & Bandyopadhyay, U. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.03.004 · Cited by 852
The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease
Erdmann, K., Cheung, B. W. Y., & Schröder, H. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.11.010 · Cited by 717
Doré, S., Takahashi, M., Ferris, C. D., Hester, L. D., Guastella, D., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2445 · Cited by 699
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
“In fact, high serum levels of bilirubin are inversely correlated with the incidence of coronary artery disease (Hopkins et al., 1996).”
BackgroundDifferent Faces of the Heme-Heme Oxygenase System in Inflammation
Wagener, F. A. D. T. G., Volk, H.-D., Willis, D., Abraham, N. G., Soares, M. P., Adema, G. J., & Figdor, C. G. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.5 · Cited by 537
Bilirubin and glutathione have complementary antioxidant and cytoprotective roles
Sedlak, T. W., Saleh, M., Higginson, D. S., Paul, B. D., Juluri, K. R., & Snyder, S. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813132106 · Cited by 530
Heme oxygenase–1, oxidation, inflammation, and atherosclerosis
Araujo, J. A., Zhang, M., & Yin, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00119 · Cited by 443
“…or serum bilirubin concentrations and the risk of CAD (Schwertner et al., 1994; Schwertner and Vitek, 2008), at a strength that was found to be similar to that of smoking, elevated systolic blood pressure, and low HDL cholesterol (Schwertner et al., 1994; Hopkins et al., 1996; Schwertner, 1998).”
BackgroundBilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant Cycle
Sedlak, T. W., & Snyder, S. H. (2004) · Pediatrics · doi:10.1542/peds.113.6.1776 · Cited by 440
Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels
Vı́tek, L., Jirsa, M., Brodanová, M., Kaláb, M., Mareček, Z., Danzig, V., Novotný, L., & Kotal, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00601-3 · Cited by 429
Yet, S.-F., Tian, R., Layne, M. D., Wang, Z. Y., Maemura, K., Solovyeva, M., Ith, B., Melo, L. G., Zhang, L., Ingwall, J. S., et al. (2001) · Circulation Research · doi:10.1161/hh1401.093314 · Cited by 420
Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction
Clark, J. E., Foresti, R., Sarathchandra, P., Kaur, H., Green, C. J., & Motterlini, R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.2.h643 · Cited by 392
Novotný, L., & Vítek, L. (2003) · Experimental Biology and Medicine · doi:10.1177/15353702-0322805-29 · Cited by 347
Lin, J.-P., O’Donnell, C. J., Schwaiger, J. P., Cupples, L. A., Lingenhel, A., Hunt, S. C., Yang, S., & Kronenberg, F. (2006) · Circulation · doi:10.1161/circulationaha.106.633206 · Cited by 314
Self-citationInduction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.
Ishikawa, K., Navab, M., Leitinger, N., Fogelman, A. M., & Lusis, A. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119634 · Cited by 289
Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodeling
Yet, S.-F., Layne, M. D., Liu, X., Chen, Y.-H., Ith, B., Sibinga, N. E. S., & Perrella, M. A. (2003) · The FASEB Journal · doi:10.1096/fj.03-0187fje · Cited by 280
Siow, R. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00278-8 · Cited by 272
Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study
Djoussé, L., Levy, D., Cupples, L. A., Evans, J. C., D’Agostino, R. B., & Ellison, R. C. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01494-1 · Cited by 263
Lanone, S., Bloc, S., Foresti, R., Almolki, A., Taillé, C., Callebert, J., Conti, M., Goven, D., Aubier, M., Dureuil, B., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2368fje · Cited by 260
Zheng, J., Inoguchi, T., Sasaki, S., Maeda, Y., McCarty, M. F., Fujii, M., Ikeda, N., Kobayashi, K., Sonoda, N., & Takayanagi, R. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00648.2011 · Cited by 201
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia.
van der Bol, J. M., Mathijssen, R. H. J., Loos, W. J., Friberg, L. E., van Schaik, R. H. N., de Jonge, M. J. A., Planting, A. S. T., Verweij, J., Sparreboom, A., & de Jong, F. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6115 · Cited by 128
Antimalarial Activity of Cocos nucifera Husk Fibre: Further Studies
Adebayo, J. O., Balogun, E. A., Malomo, S. O., Soladoye, A. O., Olatunji, L. A., Kolawole, O. M., Oguntoye, O. S., Babatunde, A. S., Akinola, O. B., Aguiar, A. C. C., et al. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/742476 · Cited by 21
Metadata
- Authors
- Hopkins, P. N., Wu, L. L., Hunt, S. C., James, B. C., Vincent, G. M., & Williams, R. R.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1996-02
- Volume
- 16
- Issue
- 2
- Pages
- 250-255
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2123008059
- Cited by
- 367
- References
- 33
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.